Researchers in South Carolina are setting up a Phase III clinical trial to test the safety and effectiveness of two FDA-approved drugs, bupropion and naltrexone, in treating methamphetamine addiction. Bupropion is sold as Wellbutrin to treat depression and Zyban to treat nicotine addiction; naltrexone, is an opiate-blocker which is sold as Vivitrol, to treat addiction. […]